.svg)
Ambros Therapeutics is a clinical-stage biotechnology company focused on the development of innovative and transformative medicine against complex regional pain syndrome type 1 (CRPS-1), a devastating rare metabolic bone disease that causes severe pain following trauma to the bone or an injury.
.svg){kind=small}
The Goal
.svg){kind=small}
Approach
.svg){kind=small}
Results
The Goal
Launch the program. As a new brand, Ambros needed to build credibility through a consistent brand identity across all assets. Ambros' ultimate goal is to streamline its fundraising and licensing efforts.
"I personally wanted to thank you for all your hard work and kindness. You were so patient and professional. I want to sincerely thank you and your team for the work you delivered. The website, brand, and visual assets have served us well, and we've appreciated the partnership."
